Rupesh Hemendra Shah

Rupesh Hemendra Shah

Active Director Managing Director DIN 00029134
DIN 00029134 First appointment Jul 2001 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Past companies 10 historical roles
Total affiliations 20 Since Jul 2001
Shareholding value •••• Premium profile

About Rupesh Hemendra Shah

Data last updated:

Rupesh Hemendra Shah is a Managing Director at Dhruvi Healthcare Private Limited (since 2022), Director at Atc Medicare Private Limited (since 2022) and Nominee Director at Anila Medical Private Limited (since 2021), and holds 7 more current directorships. The companies operate in Healthcare, Pharma and Transport and Logistics. The 9 current companies with reported revenue have a combined latest revenue of ₹1,013 Cr; the largest is Dhruvi Healthcare Private Limited at ₹634 Cr (FY 2025). Earlier, Rupesh Hemendra Shah was a Director at Medworld Pharmaceuticals Private Limited (2006–2011) and Director at Medic Remedies Private Limited (2009–2017) and 8 more.

DIN 00029134
Primary Designation Managing Director
Industry Healthcare
First Appointment 16 Jul 2001
Oldest Company Age 25 yrs
Largest company Dhruvi Healthcare Private Limited · ₹634 Cr (FY 2025)
Combined revenue ₹1,013 Cr across 9 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dhruvi Healthcare Private Limited U51909GJ2022PTC129886
Managing Director07 Mar 20222022₹634 Cr (FY 2025)Active
Atc Medicare Private Limited U51909GJ2022PTC130084
Director14 Mar 20222022₹224 Cr (FY 2025)Active
Anila Medical Private Limited U51909MP2020PTC051475
Nominee Director04 Aug 20212020₹72.79 Cr (FY 2025)Active
Rr Shipping Private Limited U63063MH2004PTC146785
Director07 Jun 20042004₹71.01 Cr (FY 2025)Active
Designated Partner11 Mar 20212021₹5.31 Cr (FY 2023)Active
Accs Logistics Private Limited U63040GJ2020PTC112519
Director04 Feb 20202020₹2.93 Cr (FY 2025)Active
Coffeebean Flavours Private Limited U55100GJ2022PTC129230
Director09 Feb 20222022₹1.85 Cr (FY 2024)Active
Director16 Mar 20042004₹93.2 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20062006₹18.6 Lakh (FY 2025)Active
Medic Remedies Private Limited U24230MH2005PTC156973
Director14 Oct 20092005₹30,747 (FY 2018)Strike Off
Golden Temple Pharma Private Limited U24239MH2006PTC164764
Additional Director01 Nov 20062006Converted To Llp
Director01 Mar 20062003₹311 Cr (FY 2025)Active
Globus Healthcare Limited U24239MH2006PLC162743
Additional Director14 Oct 20092006₹23,280 (FY 2017)Strike Off
Lancet Pharma Private Limited U24230MH2000PTC126038
Director01 Mar 20062000Converted To Llp
Goldencross Pharma Limited U24239MH2000PLC123766
Director13 Apr 20102000₹188 Cr (FY 2025)Active
Dhruvi Pharma Private Limited U24231TS2001PTC171830
Managing Director16 Jul 20012001₹472 Cr (FY 2023)Amalgamated
Medimore Pharma Private Limited U24239MH2006PTC163872
Director08 Sep 20062006Strike Off
Atc Pharma Private Limited U51909TS2019PTC173351
Nominee Director18 May 20192019₹207 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meditree Lifecare Llp
Dhruvi Pharma Private Limited
Medimore Pharma Private Limited
Yashvi Distribution Services Private Limited
Premium access

Shareholding and investment profile for Rupesh Hemendra Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupesh Hemendra Shah

Rupesh Hemendra Shah currently holds 10 directorships: Dhruvi Healthcare Private Limited (Managing Director, since 07 Mar 2022, revenue ₹634 Cr (FY 2025)); Atc Medicare Private Limited (Director, since 14 Mar 2022, revenue ₹224 Cr (FY 2025)); Anila Medical Private Limited (Nominee Director, since 04 Aug 2021, revenue ₹72.79 Cr (FY 2025)); Rr Shipping Private Limited (Director, since 07 Jun 2004, revenue ₹71.01 Cr (FY 2025)); Meditree Lifecare Llp (Designated Partner, since 11 Mar 2021, revenue ₹5.31 Cr (FY 2023)); and 5 more.

Rupesh Hemendra Shah was first appointed on 16 Jul 2001 as Managing Director at Dhruvi Pharma Private Limited. The most recent appointment on record is 14 Mar 2022 at Atc Medicare Private Limited.

The 9 current companies of Rupesh Hemendra Shah that report revenue have a combined latest revenue of ₹1,013 Cr: Dhruvi Healthcare Private Limited ₹634 Cr (FY 2025); Atc Medicare Private Limited ₹224 Cr (FY 2025); Anila Medical Private Limited ₹72.79 Cr (FY 2025); Rr Shipping Private Limited ₹71.01 Cr (FY 2025); Meditree Lifecare Llp ₹5.31 Cr (FY 2023); and 4 more.

Rupesh Hemendra Shah held 10 earlier board appointments: Medworld Pharmaceuticals Private Limited (Director, 10 Jul 2006 to 20 Apr 2011); Medic Remedies Private Limited (Director, 14 Oct 2009 to 01 Apr 2017); Golden Temple Pharma Private Limited (Additional Director, 01 Nov 2006 to 02 May 2007); Gmp Technical Solutions Private Limited (Director, 01 Mar 2006 to 20 Oct 2010); Globus Healthcare Limited (Additional Director, 14 Oct 2009 to 01 Mar 2010); and 5 more.

The current boards of Rupesh Hemendra Shah's companies include Arvind Kumar Venkat (Dhruvi Healthcare Private Limited), Deeptiben Rupeshbhai Shah (Dhruvi Healthcare Private Limited), Narasaiah Arigela (Dhruvi Healthcare Private Limited), Dhwani Dhiren Shah (Atc Medicare Private Limited), Firoz Patel (Atc Medicare Private Limited), Jayashree Ramchandra Rane (Rr Shipping Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available